Zimmer Biomet
This is a single center, prospective, randomized controlled study. The primary objective of this study is to measure migration over two years with RSA. Patients will be randomized in two arms, receiving a Taperloc Complete Reduced Distal or a Taperloc Complete Microplasty hip stem.
Hip Osteoarthritis
Noninflammatory Degenerative Joint Disease
Avascular Necrosis
Correction of Functional Deformity
Rheumatoid Arthritis
Taperloc Complete Microplasty stem
Taperloc Complete Reduced Distal stem
NA
A total of 50 patients will be enrolled into the study, randomized 1:1. All patients will receive a G7 limited hole acetabular cup with E1 liner. All potential study subjects will be required to participate in the Informed Consent process.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 50 participants |
Masking : | NONE |
Primary Purpose : | TREATMENT |
Official Title : | Randomized Controlled Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty. |
Actual Study Start Date : | 2017-05-12 |
Estimated Primary Completion Date : | 2020-11-06 |
Estimated Study Completion Date : | 2020-11-06 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years to 70 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Bravis
Roosendaal, Netherlands,